Allterum Therapeutics

Q: Where is Allterum Therapeutics located?

Allterum Therapeutics's headquarters are located at 3900 Essex Ln Ste 575, Houston, Texas, 77027, United States

Q: What is Allterum Therapeutics's official website?

Allterum Therapeutics's official website is www.allterum.com

Q: What is Allterum Therapeutics's Revenue?

Allterum Therapeutics's revenue is <$5 Million

Q: What is Allterum Therapeutics's SIC code?

Allterum Therapeutics's SIC: 28,283

Q: What is Allterum Therapeutics's NAICS code?

Allterum Therapeutics's NAICS: 32,325

Q: How many employees does Allterum Therapeutics have?

Allterum Therapeutics has <25 employees

Q: What industry does Allterum Therapeutics belong to?

Allterum Therapeutics is in the industry of: Drug Manufacturing & Research , Pharmaceuticals , Healthcare

Q: What is Allterum Therapeutics competition?

Allterum Therapeutics top competitors include: Pappas Ventures companies , Vor Biopharma , Novartis Venture Fund , Targazyme

Q: What technology does Allterum Therapeutics use?

Some of the popular technologies that Allterum Therapeutics uses are: goo.gl, WooCommerce, WordPress.org, reCAPTCHA

Q: Who is the CFO of Allterum Therapeutics?

Allterum Therapeutics's CFO is Mark Worscheh

Business Services · Texas, United States · <25 Employees

View Company Info for Free

About

Headquarters

3900 Essex Ln Ste 575, Houston, Texas, 77027, U...

Website

www.allterum.com

Revenue

<$5 Million

Industry

Drug Manufacturing & Research

Pharmaceuticals

Healthcare

Most Recent Scoops

Jan 19 2022

Funding

, an oncology-focused biotechnology company, has recently secured $64 million in Series A funding. The round was led by OrbiMed, with contributions from Nextech Invest, Vida Ventures, and others.

Dec 17 2020

Funding

, a bio-pharmaceutical company with a focus on pediatric acute lymphoblastic leukemia, has secured $1.8 million in seed funding from FanninDirect.

See all scoops

Highlights

$65.8M

Total Funding Amount

$64M

Most Recent Funding Amount

Number of Funding Rounds

View details

Who is Allterum Therapeutics

Allterum Therapeutics, Inc., is a biopharmaceutical company focusing on building an oncology franchise targeting the IL-7 axis by developing a monoclonal antibody against CD127 for the treatment of CD127 expressing cancers. Their initial focus is on relapsed/refractory hematologic malignancies such as T-cell ALL and B-cell hematologic malignancies, with plans to expand to lymphomas and solid tumors with CD127 over-expression. Working in partnership with academic collaborators, Allterum aims to provide much-needed treatment options for patients with challenging medical needs.Explore more

Is this data correct?

View contact profiles from Allterum Therapeutics

Popular SearchesAllterum Therapeutics IncAllterum Therapeutics LLCAllterum LLCAllterum TherapeuticsSIC Code 28,283NAICS Code 32,325Show more

Allterum Therapeutics Org Chart

Phone

Mark Worscheh

Chief Financial Officer

Phone

Is Allterum Therapeutics your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Last 7 days

Website visits: Recent activity has been detected on your website

Product Launch: Get notified when Allterum Therapeutics launches new products

Check if Allterum Therapeutics has recently received funding, and reach out quickly before it becomes old news!

Check out if Allterum Therapeutics is spiking on competitors!

Earning: See what the market has to say on Allterum Therapeutics recently announced quarterly report

Click to see if Allterum Therapeutics had a recent Job posting/layoffs

Funding: Get notified immidiatlly once Allterum Therapeutics has new funding data

Competitive Alert! Recent activity has been detected by your competitor Masked Content

Allterum Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic

Congratulate Masked Content for being promoted to Masked Content at Allterum Therapeutics

Recommended Actions

Find VP level buyers at Allterum Therapeutics

Find more new buyers

Compare Similar Companies to Allterum Therapeutics

Compare insights from companies similar to Allterum Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Allterum Therapeutics

<$5M

Vor Biopharma

$5.7M

Pappas Ventures companies

$5.5M

Prothix

<$5M

CytoImmune Therapeutics

<$5M

Targazyme

<$5M

Novartis Venture Fund

<$5M

View Email Formats for Allterum Therapeutics

Allterum Therapeutics financials insights

Gather financial insights about Allterum Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

Graph showing recent funding, most recent acquisition, and main investor information for Allterum Therapeutics.

See All Financials Insights

Allterum Therapeutics Employee Growth Rate

Graph showing projected employee growth data for Allterum Therapeutics

View Allterum Therapeutics’s full employee growth data

Percentage of growth

1st year Mask

2nd year Mask

Allterum Therapeutics Tech Stack

A closer look at the technologies used by Allterum Therapeutics

See more technologies

Allterum Therapeutics News & Media

GBI Biomanufacturing and Allterum Therapeutics Announce Strategic Collaboration to Manufacture Therapeutic Antibody for Clinical Trials
PLANTATION, Florida and HOUSTON, Texas, Oct. 8, 2024 /PRNewswire/ -- GBI Biomanufacturing, a leading Contract Development and Manufacturing Organization (CDMO), and Allterum Therapeutics, a Fannin-Founded Company, are pleased to announce a manufacturing partnership to advance Allterum's lead candidate 4A10 into clinic. 4A10 is a monoclonal antibody (mAb) targeting CD127, a receptor expressed by a broad variety of cancers. With this collaboration, GBI will leverage their extensive expertise in ma
Oct 7, 2024
en.prnasia.com
Fannin/Allterum awarded $2 million SBIR Phase II grant from NIH to...
Fannin Partners, LLC has received a $2 million Small Business Innovation Research (SBIR) Phase II grant from the National Cancer Institute (NCI) to advance spin-out Allterum Therapeutics’ 4A10... (PRWeb May 08, 2023) Read the full story at https://www.prweb.com/releases/2023/5/prweb19313812.htm
May 8, 2023
www.prweb.com

Top Companies in United States

Frequently Asked Questions Regarding Allterum Therapeutics

Where is Allterum Therapeutics located?

Allterum Therapeutics's headquarters are located at 3900 Essex Ln Ste 575, Houston, Texas, 77027, United States

What is Allterum Therapeutics's official website?

Allterum Therapeutics's official website is www.allterum.com

What is Allterum Therapeutics's Revenue?

Allterum Therapeutics's revenue is <$5 Million

What is Allterum Therapeutics's SIC code?

Allterum Therapeutics's SIC: 28,283

What is Allterum Therapeutics's NAICS code?

Allterum Therapeutics's NAICS: 32,325

How many employees does Allterum Therapeutics have?

Allterum Therapeutics has <25 employees

What industry does Allterum Therapeutics belong to?

Allterum Therapeutics is in the industry of: Drug Manufacturing & Research, Pharmaceuticals, Healthcare

What is Allterum Therapeutics competition?

Allterum Therapeutics top competitors include: Pappas Ventures companies, Vor Biopharma, Novartis Venture Fund, Targazyme

What technology does Allterum Therapeutics use?

Some of the popular technologies that Allterum Therapeutics uses are: goo.gl, WooCommerce, WordPress.org, reCAPTCHA

Who is the CFO of Allterum Therapeutics?

Allterum Therapeutics's CFO is Mark Worscheh

What does Allterum Therapeutics do?

What are Allterum Therapeutics social media links?

Allterum Therapeutics Linkedin page Allterum Therapeutics Twitter page

How much funding has Allterum Therapeutics raised to date?

Allterum Therapeutics has raised $65.8 Million in 2 funding rounds

When was the last funding round for Allterum Therapeutics?

Allterum Therapeutics closed its last funding round on Jan 19, 2022 with the amount of $64 Million

Who invested in Allterum Therapeutics?

Allterum Therapeutics has 5 investors including OrbiMed, Boxer Capital, Nextech Invest and Fannin Innovation Studio.

Is Allterum Therapeutics a public company?

Allterum Therapeutics is private company therefore does not currently have an official ticker symbol

See more information about Allterum Therapeutics

Allterum Therapeutics Latest Hires and Their Positions

Allterum Therapeutics is expanding and recently hired new employees. Here are the latest additions to the team.

Mark Worscheh

Chief Financial Officer

Joined May 25, 2024

Phone

Sell Smarter. Win Faster.

Level up your game to ZoomInfo Copilot, intuitive AI that turns your data and high-quality ZoomInfo data into an unfair advantage for your go-to-market teams.